Skip to content

Can Finasteride Affect Vision? A Scientific Look at Ocular Side Effects

3 min read

A 2018 study in the Investigative Ophthalmology & Visual Science (IOVS) journal found that out of 28 patients with a history of finasteride use, 25 showed evidence of visual dysfunction. So, can finasteride affect vision? Evidence suggests a potential link worth exploring.

Quick Summary

While not a universally common side effect, a growing body of evidence suggests finasteride can impact vision by causing dry eye, blurred vision, and in some cases, retinal or optic nerve damage.

Key Points

  • Hormonal Mechanism: Finasteride works by lowering DHT, a hormone that has receptors in eye glands, potentially disrupting their function.

  • Dry Eye and MGD: A common reported side effect is dry eye syndrome, linked to Meibomian Gland Dysfunction (MGD) caused by hormonal changes.

  • Blurred Vision: Blurred or fluctuating vision is a symptom associated with finasteride-induced dry eye and has also been reported as a persistent issue in Post-Finasteride Syndrome (PFS).

  • Retinal and Optic Nerve Risk: Some studies, although small, have found evidence of retinal and optic nerve damage in patients taking finasteride.

  • Macular Abnormalities: Research has suggested a link between 5-ARI drugs like finasteride and macular issues such as foveal cavitation.

  • Cataract Association: At least one case report has linked long-term finasteride use to early cataract formation and complications during cataract surgery.

  • Consult a Doctor: If you experience any vision changes while on finasteride, it is essential to consult both your prescribing physician and an ophthalmologist.

In This Article

What is Finasteride and How Does It Work?

Finasteride is a medication primarily prescribed for two conditions: androgenetic alopecia (male pattern baldness) and benign prostatic hyperplasia (BPH), or an enlarged prostate. It belongs to a class of drugs known as 5-alpha reductase inhibitors (5-ARIs). Its primary mechanism of action is to block the enzyme 5-alpha reductase, which is responsible for converting testosterone into its more potent form, dihydrotestosterone (DHT). By significantly lowering DHT levels in the body, finasteride can halt hair loss and shrink an enlarged prostate. While effective for its intended purposes, the systemic reduction of this key hormone has been linked to a range of side effects, including emerging concerns about ocular health.

The Link Between Finasteride and Vision: What Research Shows

While vision problems haven't historically been listed as common finasteride side effects, patient reports and studies are suggesting a possible connection. Ocular issues like blurred vision, dry eye syndrome, Meibomian Gland Dysfunction (MGD), and even more significant problems such as retinal damage have been reported.

Dry Eye Syndrome and Meibomian Gland Dysfunction (MGD) Finasteride may contribute to dry eye by affecting the glands responsible for tear production and the tear film's stability. Androgen receptors are found in the lacrimal and meibomian glands. By reducing DHT, finasteride can lead to an androgen deficiency that may impair these glands, potentially resulting in reduced tear production and inflammation in the lacrimal gland. A study in 2022 noted an association between finasteride use and MGD, which affects the oil-producing glands in the eyelids and can lead to evaporative dry eye. Symptoms may include a gritty feeling, burning, redness, and fluctuating blurred vision.

Blurred Vision, Retinal, and Optic Nerve Concerns Research suggests potential effects beyond the eye's surface. A study in IOVS in 2018 examined finasteride users and found indications of retinal and optic nerve damage. This included issues like macular edema and signs of optic nerve problems. The study's authors recommended considering baseline ocular testing for those prescribed 5-ARIs.

Another study in JAMA Ophthalmology linked 5-ARI use to macular abnormalities. Some individuals also experience persistent blurred vision, a reported symptom of Post-Finasteride Syndrome (PFS). A case report also connected long-term finasteride use to cataracts and a complication during cataract surgery called Intraoperative Floppy-Iris Syndrome (IFIS).

Comparison of 5-ARI Medications

Feature Finasteride Dutasteride
Mechanism Inhibits Type II 5-alpha reductase enzyme. Inhibits both Type I and Type II 5-alpha reductase enzymes.
Potency Less potent in overall DHT suppression compared to dutasteride. Considered stronger and more effective at lowering systemic DHT.
Ocular Side Effects Associated with dry eye, MGD, blurred vision, and potential retinal/optic nerve toxicity. Also linked to ocular side effects, and due to its dual-inhibition, may pose similar or greater risks.
Systemic Side Effects Includes decreased libido, erectile dysfunction, and mood changes. Similar side effect profile, potentially with a higher incidence due to greater potency.

What to Do If You Experience Vision Changes

If you are taking finasteride and experience any vision changes such as new blurriness, dry eyes, eye pain, or light sensitivity, consult your prescribing doctor and an ophthalmologist. Do not stop the medication without medical advice. An ophthalmologist can perform tests to investigate the cause of your symptoms. Symptoms like dry eye may improve after stopping the medication, though recovery can take time.

Conclusion

Evidence suggests a potential link between finasteride and vision problems. Its effect on hormones can impact ocular surface health, possibly leading to dry eye and MGD, and may be linked to retinal and optic nerve issues. Although not everyone experiences these effects, the potential risks warrant awareness. Patients using or considering finasteride should discuss potential ocular risks with their healthcare provider and seek eye care if any vision symptoms arise.

For more in-depth information on drug-induced ocular side effects, one authoritative resource is the National Center for Biotechnology Information (NCBI), part of the National Institutes of Health. Read more on NCBI.

Frequently Asked Questions

While many cases of blurred vision may resolve after stopping the medication, it has been reported as a persistent symptom in Post-Finasteride Syndrome (PFS), where effects can last indefinitely. More research is needed to understand the prevalence and reversibility.

While not officially listed as a common side effect, emerging research and case reports strongly suggest a link between finasteride and the development of dry eye and Meibomian Gland Dysfunction (MGD). It is considered a real side effect for some users.

Finasteride reduces DHT levels. Since the tear-producing lacrimal glands and oil-producing meibomian glands have androgen receptors, this hormonal disruption can impair their function, leading to decreased tear production, tear film instability, and inflammation.

Some research indicates a potential for finasteride to cause retinal toxicity. A 2018 study found evidence of retinal and optic nerve damage, including macular edema, in a small group of patients who had been on the drug.

Some researchers suggest that baseline testing is justified for individuals being prescribed 5-ARI drugs like finasteride to proactively monitor for and reduce the risk of potential visual loss.

Both are 5-ARI medications and are associated with similar ocular side effects like dry eye. Since dutasteride is a more potent DHT inhibitor, it is plausible it carries a similar or potentially greater risk, but both have been implicated in ocular issues.

You should contact your prescribing doctor and an ophthalmologist promptly. Do not stop taking the medication without medical advice. An eye exam can help determine the cause, which could be related to dry eye or more serious retinal issues.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.